The global antibody-mediated rejection prevention market is predicted to reach a valuation of US$ 89 million in 2023, with a compound annual growth rate (CAGR) of 16%, as per a recently published FMI report. Over the last decade, the complement system has emerged as an important constituent of the AMR market. Technological innovations, such as …
Category Archives: Healthcare Trends
Global Advanced Cancer Pain Management Market to reach US$ 11,540 million by 2033, growing at a 4.74% CAGR | FMI Report
The global advanced cancer pain management market is anticipated to attain an impressive valuation of USD 7265.44 million in 2023 and is estimated to reach US$ 11,540 million by 2033, trailing a CAGR of 4.74 % during the forecast period. Rapid technological advancements in neuromodulation technique for treatment of neuropathic cancer pain, surging investment to …
Orthopedic Trauma Devices Market is expected to be worth US$ 21.2 billion by 2033 | FMI Analyst
The Orthopedic Trauma Devices Market is predicted to grow at a CAGR of 7.1% over the forecast period, according to FMI’s analysis. The industry’s estimated value is predicted to increase from US$ 10.7 Billion in 2023 to US$ 21.2 Billion by 2033. The market is poised to grow at a strong rate due to a …
Knee Hyaluronic Acid Injections Market are expected to reach US$ 3.0 billion by 2031 | Says FMI Analyst
The global Knee Hyaluronic Acid Injection Market is expected to witness a stable growth rate of around 5.0% from 2021 to 2031. The global market revenue totaled US$ 1.9 Billion in 2021, according to the latest insights by Future Market Insights (FMI) survey. The overall sales of knee hyaluronic acid injections are expected to reach …
Rising Mental Health Issues Push Depression Treatment Market to reach US$ 16.8 Billion by 2032 | FMI Study
The global Depression Treatment Market is predicted to reach a valuation of US$ 16.8 Billion by 2032, with the market growing at a moderate CAGR of 5.2% from 2022 to 2032. Valued at US$ 9.7 Billion in 2021, the target market is expected to reach an estimated US$ 10.1 Billion in 2022. Different factors like …
IgA Nephropathy Market is expected to reach a valuation of US$ 85 Billion by 2033 | FMI
During the forecast period 2023-2033, the IgA Nephropathy Market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney …
Trimethoprim is expected to capture 40% of the Chronic Granulomatous Disease Market | FMI study
During the forecast period 2023-2033, the Chronic Granulomatous Disease (CGD) Management Market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Granulomatous disease (CGD) management is expected to rise up to a market valuation of US$ 2.11 Billion. It is …
Intestinal Fistula Treatment Market is expected to reach US$ 46.82 Billion | FMI
The global Intestinal Fistula Treatment Market is expected to be valued at US$ 26.64 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for intestinal fistula treatment is projected to grow at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 46.82 Billion by 2033. Factors such as …
Continue reading “Intestinal Fistula Treatment Market is expected to reach US$ 46.82 Billion | FMI”
Prinzmetal Angina Therapeutics Market is expected to reach a valuation of US$ 17.2 Billion by 2033 | FMI Report
The global Prinzmetal Angina Therapeutics Market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%. The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifestyle and rise in consumption of …
Oncolytic Virus Cancer Therapy Market is expected to be worth US$ 250 million by 2033 | FMI Analyst
According to a recent study published by Future Market Insights, the market for Oncolytic Virus Cancer Therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise …